Skip to main content

Key Insights: Treating Acute Myeloid Leukemia (AML)

May 28, 2026

Topics:  

This patient education program covers:

  • Treatment advances for AML
  • Approaches to lessen or cope with treatment side effects
  • Ways to talk with your care team about your needs and daily well-being

Speaker

Tapan Kadia, MD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, TX

Program Materials

Program Support

This program is supported by Astellas Pharma US Inc., Genentech, a member of the Roche Group, and Kura Oncology, Inc. 

 

< Back to Webcasts

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.